Back to Insights
Bullish Swing Idea

Continuation Breakout Analysis — 2026-05-28

May 28, 2026 5 min read
Tickers Mentioned
Key Takeaways
  • ALNY ($305.11): +3.2%, RVOL 1.3, between
  • APH ($147.70): +5.3%, RVOL 1.0, at_supply
  • ARGX ($838.51): +2.2%, RVOL 0.7, between
  • AVAV ($214.30): +18.2%, RVOL 4.0, between
  • BBNX ($12.12): +4.2%, RVOL 1.1, at_supply

Overview

Today’s market environment presents a Cautious Regime with a moderate number of continuation signals (48 total). While the breadth remains healthy at 55.4% above the SMA-40 and sentiment is leaning bullish/neutral, the “Cautious” regime designation requires strict selectivity. We are not looking for volume alone; we are looking for structural strength. The quality of today’s signals is heavily influenced by sector rotation, with Technology leading the charge at 5.7% ATR, followed by Real Estate and Financials. Conversely, Materials, Energy, and Utilities are lagging.

Quality Score: 3.5/5

Despite the high signal count, the Cautious regime caps our conviction. We are filtering out lower-quality setups (Bucket B0) and focusing exclusively on high-conviction institutional names in leading sectors. The sector concentration is diverse but weighted heavily toward Medical and Aerospace/Defense, which are showing significant volatility (ATR). We are prioritizing setups that offer a clear path through supply zones or those trading in high-liquidity buckets (B1/B2).

Top 5 Picks

AVAV ($214.30) — Aerospace/Defense

Technical Setup: AVAV is the standout momentum leader of the day, surging 18.2% on massive volume (RVOL: 4.0). While the price is currently trading “between” demand and supply zones, the sheer force of the breakout suggests a continuation pattern. The ATR%-M of 2.8 indicates expanding volatility, typical of a trend initiation. Although the 52-week high is still 48.7% away, the immediate supply zone is distant (17.45% above), providing a wide runway for the breakout to run. The high ADR (5.7%) confirms the stock is capable of sustaining this move.

Level Price Notes
Entry $214.30 Current Market Price / Breakout Confirmation
Stop Loss $199.10 Below recent consolidation support (approx 7% risk)
Target 1 $235.00 Initial resistance test
Target 2 $251.70 Approaching major Supply Zone

Institutional Backing: Supported by 638 funds (Bucket B1, B2), indicating strong institutional interest despite the recent volatility.

WAT ($366.72) — Medical-Systems

Technical Setup: WAT is trading directly “at_supply” with a price of $366.72, sitting just 0.41% below the lower boundary of its weekly supply zone ($368.23). This is a high-stakes breakout setup. The stock is up 7.2% on 1.6x volume (RVOL) with a massive ATR%-M of 4.0, signaling a potential breakout through the ceiling. If it clears $368.23, the path opens toward the upper supply bound at $389.82. The monthly demand zone strength is moderate (4.2), but the immediate weekly supply strength is high (8.3), meaning a breakout here must be decisive.

Level Price Notes
Entry $368.50 Breakout above Weekly Supply Low
Stop Loss $355.00 Below the breakout candle low
Target 1 $378.00 Mid-range of supply zone
Target 2 $389.82 Upper Weekly Supply Limit

Institutional Backing: Heavy institutional support with 2411 funds (Bucket B1), providing liquidity for the breakout.

GWRE ($142.16) — Software (Financial)

Technical Setup: GWRE is another “at_supply” candidate, currently trading at $142.16, just 2.76% below its supply zone ($146.08). The sector (Software) is not the top leader today, but GWRE shows a solid 6.7% gain with 1.2x volume. The risk profile is favorable: the demand zone is relatively close (8.46% below), offering a defined risk area. With a 52-week low of 23.0% and a current price significantly recovered, the momentum is building to test the $146.08 ceiling. A close above this level confirms the continuation.

Level Price Notes
Entry $146.50 Breakout above Supply Low
Stop Loss $138.00 Below recent swing low
Target 1 $152.00 Initial extension
Target 2 $158.00 Next resistance area

Institutional Backing: Backed by 833 funds (Bucket B2), showing steady accumulation.

ALNY ($305.11) — Medical (Revenue Biotech)

Technical Setup: ALNY is trading in the “between” zone, sitting comfortably above its daily demand zone (Strength 3.9) and well below the supply zone (15.36% away). The stock is up 3.2% with 1.3x volume. While the RVOL is moderate, the price action is clean. The 52-week high is still 38.4% away, providing ample room for a trend. The key here is the stability; the stock is not fighting immediate supply pressure like WAT or GWRE, allowing for a more sustainable grind higher. The ATR risk is high (115.5%), so position sizing must be adjusted.

Level Price Notes
Entry $305.11 Current Market Price
Stop Loss $292.00 Below Daily Demand Upper
Target 1 $325.00 Intermediate resistance
Target 2 $351.96 Approaching Supply Zone

Institutional Backing: Strong institutional presence with 2240 funds (Bucket B1, B2).

FTAI ($262.60) — Aerospace/Defense

Technical Setup: FTAI is a unique “between” setup with no supply zone identified in the immediate timeframe (Supply: null). This is a rare and powerful continuation signal. The stock is up 4.9% with low volume (RVOL 0.6), but the lack of overhead supply suggests a potential vacuum for price discovery. The demand zone is strong (Strength 7.6) and located 17.37% below, providing a wide safety net. In a Cautious regime, a stock with no defined supply ceiling is a prime candidate for a “runaway” trade if momentum picks up.

Level Price Notes
Entry $262.60 Current Market Price
Stop Loss $245.00 Below recent consolidation
Target 1 $285.00 Psychological resistance
Target 2 $300.00 Next major milestone

Institutional Backing: 972 funds (Bucket B1), indicating solid institutional ownership.

Honorable Mentions

  • APH ($147.70): Trading at supply with a tight distance (0.9%), a breakout here could trigger a rapid move to $153.36.
  • HOLO ($2.27): High volatility (14.1% gain) with massive RVOL (3.3), but low institutional backing makes it a speculative momentum play.
  • SCCO ($194.71): Mining sector laggard but showing strength; no supply zone identified, similar to FTAI, offering a clear path up.
  • BBNX ($12.12): At supply with a tight range; requires a decisive close above $12.27 to confirm continuation.
  • ARGX ($838.51): Solid profitable biotech in a “between” zone, though lower volume (RVOL 0.7) suggests a slower grind.

Strategy Summary

Today’s continuation setups are characterized by high volatility and sector-specific strength in Aerospace/Defense and Medical. The Cautious Regime dictates that we avoid chasing stocks that are already extended without clear support, and instead focus on those breaking out of defined zones or trading in vacuum-like conditions (FTAI, SCCO).

Key Sectors: Aerospace/Defense (AVAV, FTAI) and Medical (WAT, ALNY) are the primary drivers. Technology is leading the broader market but lacks specific breakout candidates in the top 5 list today.

Risk/Reward: The risk/reward is asymmetric for the top picks. FTAI and WAT offer the highest potential reward due to the lack of immediate supply or the potential for a breakout. However, the high ATR values (e.g., AVAV at 156.8%) require strict stop-loss adherence. We recommend entering on confirmed breakouts rather than anticipating moves, especially in the “at_supply” candidates.

Share: